- Research Article
- 10.11648/j.sjcm.20211004.23
US COVID-19 State Mortality and Case Progression – A Second Midterm Report Card (Delta Surge)
- Jan 01, 2021
- Science Journal of Clinical Medicine
- Vernon Wen-Hau Lin + 2 more +2
The US has led the world with over 667,000 deaths due to COVID-19, partly fueled by the spread of the Delta Variant since the spring of 2021. The “Delta Surge” has especially impacted the southern states, despite the rolling out of three effective vaccines (Pfizer/BioNTech’s Comirnaty, Moderna, and Johnson & Johnson’s Jansen) since early 2021. This is an interim report of each state (50 states, Washington DC, and Puerto Rico), in terms of mortality rate (MR, the number of cumulative deaths per 100,000 population due to COVID-19 by July 27<sup>th</sup>, 2021) and Case Rate Progression (CRP, the percent change in the number of cumulative cases per 100,000 population increased from June 1<sup>st</sup> to August 1<sup>st</sup>, 2021). The study provided an A-F grade report card for each state when compared to one another. The results showed that the states that received F’s in MR are the following (starting from the worst): New Jersey, New York, Massachusetts, Rhode Island, and Mississippi. The 3 states that received an A rating were (starting from the best): Hawaii, Vermont, and Alaska. The following states received F’s in CRP (starting from the worst): Louisiana, Arkansas, Florida, Missouri, Nevada, and Mississippi. A poor CRP grade reflects rampant increases in new COVID-19 cases, followed by resulting increases in hospitalization, health resource utilization, and mortality. It is critical that we as a nation remain vigilant to observe these lingering effects of COVID-19 by participating in public health efforts, continuing to vaccinate the public, and observing social distancing, healthy hygiene practices, and masking as per CDC guidance.
Read more